Centessa Pharmaceuticals (CNTA)
NASDAQ: CNTA
· Real-Time Price · USD
18.03
0.39 (2.21%)
At close: Aug 15, 2025, 3:59 PM
18.05
0.11%
After-hours: Aug 15, 2025, 04:34 PM EDT
Centessa Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -223.85M | -235.76M | -161.59M | -157.67M | -138.74M | -151.41M | -157.42M | -172.65M | -212.42M | -216.21M | -233.94M | -220.04M | -196.75M | -382.54M | -324.92M | -287.08M | -247.94M |
Depreciation & Amortization | 916.87K | 939.87K | 960.14K | 962.14K | 963.14K | 812.14K | 600K | 397K | 192K | 131K | 107.01K | 84.95K | 59.95K | 33.96K | 21.95K | 9.01K | 2.01K |
Stock-Based Compensation | 33.27M | 33.55M | 32.65M | 31.75M | 30.36M | 29.39M | 28.58M | 28.05M | 26.44M | 24.96M | 23.11M | 20.21M | 17.84M | 14.85M | 10.18M | 6.08M | 2.94M |
Other Working Capital | 33.71M | 27.58M | -5.64M | -10.43M | -10.81M | -2.87M | -23.44M | -14.98M | -6.24M | -9.18M | 2.04M | 3.05M | -5.32M | 1.34M | 6.36M | 1.16M | 5.25M |
Other Non-Cash Items | 33.53M | 34.63M | 2.2M | 3.56M | 6.53M | 6.4M | 6.3M | 6.3M | -3.72M | -3.61M | -2.38M | 8.72M | 33.81M | 258.53M | 255.76M | 244.32M | 226.54M |
Deferred Income Tax | 3.2M | 2.64M | 2.12M | -2.02M | -26.23M | -26.66M | -29.39M | -26.63M | -2.99M | -2.99M | -135K | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 31.11M | 21.95M | -6.7M | -22.95M | -22.72M | -18.93M | -29.53M | -18.02M | -5.86M | -2.83M | 9.27M | 2.07M | -11.41M | -5.38M | -3.85M | -3.95M | 3.39M |
Operating Cash Flow | -162.01M | -142.06M | -130.36M | -146.36M | -149.84M | -160.39M | -180.86M | -182.55M | -198.37M | -200.55M | -205.27M | -199.5M | -173.49M | -136.14M | -83.13M | -51.71M | -19.66M |
Capital Expenditures | -34K | -34K | -62.03K | -71.03K | -81.03K | -169.03K | -793K | -766K | -985K | -1.14M | -548.7K | -580.92K | -388.85K | -185.98K | -122.28K | -74.05K | -37.13K |
Cash Acquisitions | n/a | n/a | 18.25M | -68.38M | -68.38M | -68.38M | -86.63M | n/a | n/a | n/a | -153.75K | -53.95K | -339.76K | 63.43M | 63.59M | 63.49M | 63.77M |
Purchase of Investments | -195.52M | 6.87M | -63.94M | -248.27M | -198.83M | -265.08M | -194.84M | -157.34M | -86.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 134.54M | 171.3M | 198.87M | 240.5M | 175.37M | 138.61M | 86.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -146.3M | -129.54M | -148.37M | 84.71M | 13.67M | -89.34M | -70.88M | -157.13M | -86.04M | 206K | 4.6M | 4.6M | 4.48M | n/a | -4.6M | -4.6M | -4.48M |
Investing Cash Flow | -207.88M | 31.27M | -12.02M | -8.28M | -23.92M | -127.02M | -109.17M | -157.9M | -87.03M | -931K | -702.45K | -634.87K | -728.61K | 63.25M | 63.47M | 63.41M | 63.74M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 73.64M | 73.64M | 73.64M | 73.64M | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 29.08 | 10.20 | -12K | -12K | -12.03K | -12.01K | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 7.39M | 5.15M | 2.27M | -823K | 1.15M | 310K | 281K | 325K | 383K | 457K | 663.68K | 144K | 345.49M | 587.3M | 588.29M | 588.66M | 243.25M |
Financial Cash Flow | 357.35M | 364.75M | 368.17M | 136.93M | 31.63M | 21.13M | 14.85M | 325K | 383K | 457K | 73.37M | 72.07M | 417.42M | 660.07M | 588.35M | 589.5M | 244.09M |
Net Cash Flow | -13.06M | 255.19M | 223.53M | -17.85M | -141.77M | -265.61M | -273.35M | -338.94M | -284.48M | -201.44M | -133.97M | -135.86M | 233.34M | 575.34M | 557.43M | 597.31M | 286.54M |
Free Cash Flow | -162.05M | -142.09M | -130.42M | -146.43M | -149.92M | -160.56M | -181.65M | -183.32M | -199.35M | -201.68M | -205.82M | -200.08M | -173.88M | -136.33M | -83.26M | -51.78M | -19.69M |